Human Rabies Immunoglobulin (IM) Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2021-2028

The global Human Rabies Immunoglobulin (IM) market was valued at 27.93 Million USD in 2020 and will grow with a CAGR of 7.34% from 2020 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient`s passive immunization. The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017. For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU. Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%. China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.

GET FREE SAMPLE PDF: https://www.wiseguyreports.com/sample-request/6847599-global-human-rabies-immunoglobulin-im-market-research-report

By Market Verdors:

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

By Types:

ERIG

HRIG

By Applications:

Category II Exposure

Category III Exposure

REPORT DETAILS: https://www.wiseguyreports.com/reports/6847599-global-human-rabies-immunoglobulin-im-market-research-report

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

ALSO READ: http://www.marketwatch.com/story/vitamin-b12-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2020-2025-2021-06-22

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

ALSO READ: http://www.marketwatch.com/story/comic-book-market-research-report-with-size-share-value-cagr-outlook-analysis-latest-updates-data-and-news-2021-2028-2021-06-23

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Human Rabies Immunoglobulin (IM) Revenue

1.4 Market Analysis by Type

1.4.1 Global Human Rabies Immunoglobulin (IM) Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 ERIG

1.4.3 HRIG

1.5 Market by Application

ALSO READ: http://www.marketwatch.com/story/charity-accounting-software-market-size-share-value-and-competitive-landscape-2021-2026-2021-06-24-7175543

1.5.1 Global Human Rabies Immunoglobulin (IM) Market Share by Application: 2022-2027

1.5.2 Category II Exposure

1.5.3 Category III Exposure

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Human Rabies Immunoglobulin (IM) Market

1.8.1 Global Human Rabies Immunoglobulin (IM) Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

Continued…

CONTACT DETAILS:

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105

Source – HeraldKeeper
Note: The Heraldkeeper News Department was not involved in the creation of this content.

If you have any problem with this press release? Contact the source provider Heraldkeeper.com, you can contact them here.

Related Articles

Stay Connected

0FansLike
3,040FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles